These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 37103043)

  • 1. Antithrombotic Therapy in Peripheral Artery Disease: Current Evidence and Future Directions.
    Canonico ME; Piccolo R; Avvedimento M; Leone A; Esposito S; Franzone A; Giugliano G; Gargiulo G; Hess CN; Berkowitz SD; Hsia J; Cirillo P; Esposito G; Bonaca MP
    J Cardiovasc Dev Dis; 2023 Apr; 10(4):. PubMed ID: 37103043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary Review of Antithrombotic Therapy in Peripheral Artery Disease.
    Hess CN; Bonaca MP
    Circ Cardiovasc Interv; 2020 Oct; 13(10):e009584. PubMed ID: 33023325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of vorapaxar on cardiovascular and limb outcomes in patients with peripheral artery disease with and without coronary artery disease: Analysis from the TRA 2°P-TIMI 50 trial.
    Qamar A; Morrow DA; Creager MA; Scirica BM; Olin JW; Beckman JA; Murphy SA; Bonaca MP
    Vasc Med; 2020 Apr; 25(2):124-132. PubMed ID: 32000630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
    Alonso-Coello P; Bellmunt S; McGorrian C; Anand SS; Guzman R; Criqui MH; Akl EA; Vandvik PO; Lansberg MG; Guyatt GH; Spencer FA
    Chest; 2012 Feb; 141(2 Suppl):e669S-e690S. PubMed ID: 22315275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical Therapy for Secondary Prevention of Atherothrombotic Events in Peripheral Artery Disease.
    Morrison JT; Hsia J; Bonaca MP
    Heart Int; 2021; 15(1):14-19. PubMed ID: 36277318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic therapy in peripheral arterial disease.
    Espinola-Klein C; Weißer G; Schmitt V; Schwaderlapp M; Munzel T
    Front Cardiovasc Med; 2022; 9():927645. PubMed ID: 36312276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic strategies for patients with coronary and lower extremity peripheral artery diseases: a narrative review.
    De Luca L; Bonaca MP; Magnani G
    Expert Rev Cardiovasc Ther; 2020 Dec; 18(12):881-889. PubMed ID: 33021875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vorapaxar for Prevention of Major Adverse Cardiovascular and Limb Events in Peripheral Artery Disease.
    Morrison JT; Govsyeyev N; Hess CN; Bonaca MP
    J Cardiovasc Pharmacol Ther; 2022; 27():10742484211056115. PubMed ID: 35006035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary Medical Management of Peripheral Artery Disease.
    Bonaca MP; Hamburg NM; Creager MA
    Circ Res; 2021 Jun; 128(12):1868-1884. PubMed ID: 34110910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotics in stable peripheral artery disease.
    Kaplovitch E; Rannelli L; Anand SS
    Vasc Med; 2019 Apr; 24(2):132-140. PubMed ID: 30799766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease: The COMPASS Trial.
    Anand SS; Caron F; Eikelboom JW; Bosch J; Dyal L; Aboyans V; Abola MT; Branch KRH; Keltai K; Bhatt DL; Verhamme P; Fox KAA; Cook-Bruns N; Lanius V; Connolly SJ; Yusuf S
    J Am Coll Cardiol; 2018 May; 71(20):2306-2315. PubMed ID: 29540326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do we have a unified consensus on antithrombotic management of PAD?
    Poredos P; Antignani PL; Blinc A; Fras Z; Jezovnik MK; Fareed J; Mansilha A
    Int Angiol; 2021 Jun; 40(3):229-239. PubMed ID: 33739074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombotic treatment in peripheral artery disease.
    Olinic DM; Tataru DA; Homorodean C; Spinu M; Olinic M
    Vasa; 2018 Feb; 47(2):99-108. PubMed ID: 29160765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual Antiplatelet Therapy or Antiplatelet Plus Anticoagulant Therapy in Patients with Peripheral and Chronic Coronary Artery Disease: An Updated Review.
    Magnani G; Denegri A; Gurgoglione FL; Barocelli F; Indrigo E; Catellani D; Signoretta G; Bettella A; Tuttolomondo D; Solinas E; Nicolini F; Niccoli G; Ardissino D
    J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral arterial disease: pathophysiology, risk factors, and role of antithrombotic therapy.
    Bradberry JC
    J Am Pharm Assoc (2003); 2004; 44(2 Suppl 1):S37-44; quiz S44-5. PubMed ID: 15095934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-World Predictors of Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients with Chronic Coronary Artery Disease and/or Peripheral Arterial Disease.
    Berger A; Simpson A; Leeper NJ; Murphy B; Nordstrom B; Ting W; Zhao Q; Berger J
    Adv Ther; 2020 Jan; 37(1):240-252. PubMed ID: 31705434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-Experience Gap and Future Perspective on the Treatment of Peripheral Artery Disease.
    Iida O; Takahara M; Mano T
    J Atheroscler Thromb; 2021 Dec; 28(12):1251-1259. PubMed ID: 34078765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and Cost of Major Adverse Cardiovascular Events and Major Adverse Limb Events in Patients With Chronic Coronary Artery Disease or Peripheral Artery Disease.
    Berger A; Simpson A; Bhagnani T; Leeper NJ; Murphy B; Nordstrom B; Ting W; Zhao Q; Berger JS
    Am J Cardiol; 2019 Jun; 123(12):1893-1899. PubMed ID: 31014542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic Treatment for Symptomatic Peripheral Artery Disease.
    Li YH; Yeh HI; Hwang JJ
    Acta Cardiol Sin; 2019 Nov; 35(6):557-562. PubMed ID: 31879506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.